| Literature DB >> 28228115 |
Stephen P Messier1,2,3, Leigh F Callahan4, Daniel P Beavers5, Kate Queen6, Shannon L Mihalko7, Gary D Miller7, Elena Losina8, Jeffrey N Katz8, Richard F Loeser4, Sara A Quandt9, Paul DeVita10, David J Hunter11, Mary F Lyles12, Jovita Newman7, Betsy Hackney4, Joanne M Jordan4.
Abstract
BACKGROUND: Recently, we determined that in a rigorously monitored environment an intensive diet-induced weight loss of 10% combined with exercise was significantly more effective at reducing pain in men and women with symptomatic knee osteoarthritis (OA) than either intervention alone. Compared to previous long-term weight loss and exercise trials of knee OA, our intensive diet-induced weight loss and exercise intervention was twice as effective at reducing pain intensity. Whether these results can be generalized to less intensively monitored cohorts is unknown. Thus, the policy relevant and clinically important question is: Can we adapt this successful solution to a pervasive public health problem in real-world clinical and community settings? This study aims to develop a systematic, practical, cost-effective diet-induced weight loss and exercise intervention implemented in community settings and to determine its effectiveness in reducing pain and improving other clinical outcomes in persons with knee OA. METHODS/Entities:
Keywords: Clinical trial; Community based research; Knee pain; Osteoarthritis; Pragmatic
Mesh:
Year: 2017 PMID: 28228115 PMCID: PMC5322619 DOI: 10.1186/s12891-017-1441-4
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Our model developed for IDEA and used for we-can indicating the pathways by which intensive weight loss and exercise can decrease joint loads and inflammation leading to decreased pain and improved mobility and health related quality of life
Fig. 2we-can organizational structure
Exclusion criteria
| Criteria | Exclusion | Method |
|---|---|---|
| Significant co-morbid disease that would pose a safety threat or impair ability to participate; low BMI; no knee OA | Symptomatic or severe coronary artery disease; unable to walk without assistive device; blindness; type 1 diabetes; BMI < 27.0 kg/m2, does not meet ACR clinical criteria for knee OA | Medical history; knee exam using ACR clinical criteria and performed by research staff trained by our MDs |
| Ability and willingness to modify dietary or exercise behaviors | Unwillingness or inability to change eating and physical activity habits due to environment; cannot speak and read English | Questionnaire, assessment by interventionists |
| Ability to finish or to comply with the 18-month study | Planning to leave area ≥ 2 months during the next 18 months | Questionnaire |
| Significant cognitive impairment | Montreal Cognitive Assessment (MOCA) | Medical history, MOCA |
| Transportation | Unable to provide own transportation to and from the intervention site | Questionnaire |
Description of intervention sites by county
| County | Site Name | Description | Size (sq.ft) | Exercise | Nutrition |
|---|---|---|---|---|---|
| Forsyth | Healthy Exercise Lifestyle Programs | Community, university setting | 20,000 | track, aerobic equipment strength equipment | 2 classrooms |
| Smiley Fitness | Private | 2,200 | aerobic, strength equip. | 1 classroom | |
| St. Peter’s World Outreach Center | Church | 73,000 | track, strength equipment. | 2 classrooms with kitchen | |
| Johnston | Johnston Health Care Medical Mall | Facility within Medical Mall affiliated with Hospital | 197,000 | Track, strength equipment | 1 classrooms |
| Clayton Community Center | Parks/Rec Center | 34,000 | Track, aerobic equipment strength equipment | 2 classrooms | |
| Haywood | MedWest Fitness Center | Hospital Fitness Center | 54,000 | Track, aerobic equipment strength equipment | 2 classrooms |
Summary of diet-induced weight loss plan and number of planned contacts
| Months | Weight loss plan | Meal Replacements or equivalent per day (N) | Contacts per month (N) | ||
|---|---|---|---|---|---|
| Total | Individual | Group | |||
| 0-6 | Energy restriction 800–1000 kcals/day | 1-2 | 4 | 2a | 2 |
| 7-12 | Either continued energy restriction or weight maintenance once 10% weight loss reached | 0-1 | 2 | 1a | 1 |
| 13-18 | Either continued energy restriction or weight maintenance once 10% weight loss reached | 0-1 | 1 | 1a | none |
aIndividual contacts will alternate between face-to-face and a method preferred by the participant (i.e., phone, email, text, etc.)
Reporting of serious adverse events
| Type of Event | Reporting Requirements | Reporting Requirements | Reporting Requirements |
|---|---|---|---|
| Initial Report | Clinical Site | Safety Committee | |
| Serious Adverse Events (SAE) | Reported to Site PI/Physician immediately | Within 24 h of initial receipt of the information Clinical Site will report to Safety Committee | Within 24 h of initial receipt of the information Safety Committee will report to NIAMS (48 h from initial report) |
| Non serious Adverse Events (AE) | Reported to Site PI/Physician within 7 days | Reported in monthly correspondence to Safety Committee | Reported in Bi-annual correspondence to NIAMS |
Study time line with milestones
| Planning Months1-6 | 1st subject enrolled in intervention | 25% enrolled | 50% enrolled | 75% enrolled | 100% enrolled | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Wave 1 | Wave 2 | Wave 3 | Wave 4 | Wave 5 | Wave 6 | Wave 7 | Wave 8 | Wave 9 | Wave 10 | |
| Recruitment | months 7-9 | 10-12 | 13-15 | 16-18 | 19-21 | 22-24 | 25-27 | 28-30 | 31-33 | 34-36 |
| Intervention | 10-27 | 13-30 | 16-33 | 19-36 | 22-39 | 25-42 | 28-45 | 31-48 | 34-51 | 37-54 |
| N | 82 | 164 | 246 | 328 | 410 | 492 | 574 | 656 | 738 | 820 |
| Analysis and Final Report: Months 54-60 | ||||||||||
Measurements with screening and follow-up visit schedule
| Measurements | PSV | SV1 | FU6 | FU12 | FU18 | Explanation |
|---|---|---|---|---|---|---|
| Questionnaires | ||||||
| Informed Consent | x | |||||
| Eligibility Questionnaire | x | To determine eligibility | ||||
| Medical History | xc | x | x | x | x | For eligibility and to document changes in health |
| Risk Stratification | xc | x | Used to screen for cardiovascular risk [ | |||
| Comorbidities Questionnaire | x | x | x | x | [ | |
| Randomization | x | |||||
| WOMAC | x | x | x | x | Pain is primary outcome [ | |
| KOOS | x | x | x | x | Pain, symptoms, ADL, sport, recreation, knee QOL [ | |
| ICOAP | x | x | x | x | Intermittent and constant osteoarthritis pain, 2 sleep questions [ | |
| Cost Effectiveness | x | x | x | x | ||
| PASE scale | x | x | x | x | Physical Activity Scale for the Elderly [ | |
| MOCA | x | x | Montreal Cognitive Assessment [ | |||
| CES-D | x | x | x | x | The Center for Epidemiologic Studies Depression Scale [ | |
| EuroQol Quality of Life(EQ5D) | x | x | x | x | Quality of life measure [ | |
| Work History Resource | x | x | x | x | Visits to clinicians, tests, medications, injections, surgery, alternative therapies | |
| Work Productivity and Activity Impairment Index | x | x | x | x | Assesses absenteeism and presenteeism [ | |
| DHQ II | x | x | x | x | NIH Diet History Questionnaire [ | |
| SF-36 | x | x | x | x | Health related quality of life [physical, mental] [ | |
| Self-Efficacy-Adherence | x | x | x | x | Belief can exercise over time [ | |
| Perceived Stress (PSS) | x | x | x | x | The degree to which people perceive their lives as stressful [ | |
| Pain Catastrophizing Scale (PCS) | x | x | x | x | Catastrophizing [rumination, magnification, and helplessness] [ | |
| Healthy Literacy | x | x | x | x | Functional health literacy [ | |
| Walking Efficacy for Duration | x | x | x | x | Confidence in walking for different durations [ | |
| Gait Efficacy | x | x | x | x | Confidence in completing gait related tasks [ | |
| Weight Efficacy Lifestyle Questionnaire (WEL) | x | x | x | x | Self-Efficacy for weight management [ | |
| Positive and Negative Affect Scale (PANAS) | x | x | x | x | Positive and Negative Affect [ | |
| Demographics | x | |||||
| Medication form | x | x | x | x | Atherosclerosis Risk in Communities form [ | |
| Satisfaction With Life Scale | x | x | x | x | Quality of life [ | |
| Physical Performance Tests/Knee Exam | ||||||
| Height and weight | x | x | To determine BMI | |||
| Adverse Events | x | x | x | x | Also collected as they occur | |
| Knee exam | x | To determine eligibility | ||||
| Pain Severity | x | x | x | To determine MCID [ | ||
| 6 min walk | x | x | x | x | Measure of mobility [ | |
| Expanded Short Physical Performance Battery (SPPB) | x | x | x | x | Gait speed, sit to stand, balance tests; predicts disability [ | |
| Functional Leg Strength | x | x | x | x | Sit to stand test, part of SPPB | |
| Blood Pressure | x | x | x | x | Overall health measure | |
| GAITRite gait analysis | x | x | x | x | Temporospatial gait variables | |
| Stair climb | x | x | x | x | Timed Stair ascent and descent [ | |
xc brief screen by self-report, PSV Prescreening Visit, SV screening visit, FU follow-up 6, 12, 18 months after screening visit, MCID minimally clinically important difference
Fig. 3Participant eligibility and screening flow chart. BMI = body mass index; CHD = cardiovascular heart disease; ACR = American College of Rheumatology